| Literature DB >> 34657488 |
Julia Fee Voon Ho1, Nur Syafiqah Marzuki1, Nur Syuhadah Monica Meseng1, Viknaswary Kaneisan1, Yin Khek Lum1, Eunice Wan Wen Pui2, Hayati Yaakup1.
Abstract
OBJECTIVES: Achievement of patients' preferred place of death is recognized as a component of a good death. This study aimed to investigate the symptom burden in advanced cancer patients, achievement of their place of death preferences and factors associated with home death.Entities:
Keywords: cancer; geriatrics; home death; palliative care; place of death preference; symptom
Mesh:
Year: 2021 PMID: 34657488 PMCID: PMC9210115 DOI: 10.1177/10499091211048767
Source DB: PubMed Journal: Am J Hosp Palliat Care ISSN: 1049-9091 Impact factor: 2.090
Figure 1.Distribution of cancer diagnoses in patients who passed away under the care of the palliative care unit (n = 287). *Three patients had 2 concurrent tumors, 1 had 3 concurrent malignancies. GIST indicates gastrointestinal stromal tumor.
Figure 2.Indications for palliative care referral. *There was incomplete data for 6 patients, thus these patients were excluded from analysis.
Figure 3.Symptom prevalence observed at first palliative care consultation. *Six patients were excluded due to incomplete data on symptom prevalence.
Figure 4.Comparison between preferred and actual place of death and achievement of preferred place of death. (a) 34 of 287 patients were excluded (9 patients were lost to follow-up, 13 were transferred to another center, and 12 deteriorated acutely before preferences regarding place of death could be established). (b) 9 of 253 patients who expressed no preference for place of death were excluded. (c) 12 of 253 patients were excluded (9 patients with no preference for place of death, and 3 who were lost to follow-up).
Comparisons Between Patient Variables, Preferred Place of Death and Actual Place of Death (n=237)*
| Patient variables | Preferred place of death | Actual place of death | |||||
|---|---|---|---|---|---|---|---|
| Home | Hospital | Home | Hospital | ||||
| Mean age (years) | 62.73 | 58.06 |
| 63.19 | 58.27 |
| |
| Standard deviation SD | 14.15 | 16.5 | 14.37 | 16.01 | |||
| Gender | |||||||
| Female | 66 | 50 | 0.602 | 63 | 53 | 0.052 | |
| Male | 64 | 57 | 50 | 71 | |||
| Marital status | |||||||
| Married | 115 | 89 | 98 | 106 | |||
| Single | 14 | 17 | 14 | 17 | |||
| Divorced | 1 | 1 | 1 | 1 | |||
| Cancer diagnosis | |||||||
| Lung | 22 | 19 | 0.764 | 22 | 19 | 0.575 | |
| Colorectal | 15 | 13 | 14 | 14 | |||
| Breast | 13 | 16 | 10 | 19 | |||
| Pancreatic | 11 | 11 | 12 | 10 | |||
| Gastroesophageal | 14 | 9 | 7 | 16 | |||
| Hepatocellular | 14 | 4 | 12 | 6 | |||
| Cholangiocarcinoma | 9 | 5 | 9 | 5 | |||
| Nasopharyngeal | 8 | 3 | 6 | 5 | |||
| Renal | 4 | 2 | 3 | 3 | |||
| Male reproductive | 2 | 5 | 2 | 5 | |||
| Sarcoma | 2 | 4 | 2 | 4 | |||
| Gynaecological | 4 | 3 | 4 | 3 | |||
| Haematological | 1 | 3 | 0 | 4 | |||
| Brain | 1 | 2 | 1 | 2 | |||
| Oral | 2 | 1 | 2 | 1 | |||
| Thyroid | 2 | 2 | 2 | 2 | |||
| Melanoma | 2 | 1 | 2 | 1 | |||
| Laryngeal | 1 | 0 | 0 | 1 | |||
| Bladder | 1 | 1 | 1 | 1 | |||
| Neuroendocrine | 1 | 1 | 1 | 1 | |||
| Unknown primary | 1 | 1 | 1 | 1 | |||
| GIST | 0 | 1 | 0 | 1 | |||
| Symptoms | |||||||
| Pain | Present | 102 | 78 | 0.319 | 89 | 91 | 0.334 |
| Absent | 28 | 29 | 24 | 33 | |||
| Dyspnea | Present | 66 | 52 | 0.739 | 54 | 64 | 0.556 |
| Absent | 64 | 55 | 59 | 60 | |||
| Weakness/lack of energy | Present | ||||||
| Absent | 115 | 96 | 0.758 | 101 | 110 | 0.869 | |
| 15 | 11 | 12 | 14 | ||||
| Nausea | Present | 38 | 46 |
| 28 | 56 |
|
| Absent | 92 | 61 | 85 | 68 | |||
| Vomiting | Present | 30 | 38 |
| 21 | 47 |
|
| Absent | 100 | 69 | 92 | 77 | |||
| Poor appetite | Present | 97 | 79 | 0.891 | 84 | 92 | 0.980 |
| Absent | 33 | 28 | 29 | 32 | |||
| Constipation | Present | 75 | 76 |
| 63 | 88 |
|
| Absent | 55 | 31 | 50 | 36 | |||
| Sore or dry mouth | Present | 66 | 41 | 0.055 | 53 | 54 | 0.604 |
| Absent | 64 | 66 | 60 | 70 | |||
| Drowsiness | Present | 45 | 40 | 0.658 | 37 | 48 | 0.339 |
| Absent | 85 | 67 | 76 | 76 | |||
| Poor mobility | Present | 99 | 81 | 0.935 | 87 | 93 | 0.720 |
| Absent | 31 | 26 | 26 | 31 | |||
Abbreviation: GIST, gastrointestinal stromal tumor.
*16 patients were excluded from the analysis: 9 patients had no preference for the place of death, 1 chose a temple as the place of death, and 6 were excluded due to incomplete data on their symptom prevalence.
**Associations between patient variables and the preferred and actual place of death were analyzed using chi-squared test (gender, marital status, cancer diagnosis, symptoms) and independent t-test (mean age); a p-value <0.05 was considered statistically significant and indicated in bold.
Multivariate Logistic Regression Analysis of Patient Variables With the Preferred and Actual Place of Death.
| Patient variables | Multivariate analysis OR (95% CI) | Multivariate analysis OR (95% CI) | ||||
|---|---|---|---|---|---|---|
| Home | Hospital | p-value | Home | Hospital | p-value | |
| Mean age | 1.021 (1.0041.039) | 1 (Ref)** |
| 1.023 (1.005-1.041) | 1 (Ref) |
|
| Absence of nausea | 1.323 (0.588-2.979) | 0.499 | 1.517 (0.670-3.432) | 0.317 | ||
| Presence of nausea | 1 (Ref) | 1 (Ref) | ||||
| Absence of vomiting | 1.243 (0.527-2.935) | 0.619 | 1.668 (0.694-4.008) | 0.253 | ||
| Presence of vomiting | 1 (Ref) | 1 (Ref) | ||||
| Absence of constipation | 1.628 (0.904-2.931) | 0.104 | 1.578 (0.881-2.829) | 0.125 | ||
| Presence of constipation | 1 (Ref) | 1 (Ref) | ||||
Abbreviations: OR, odds ratio; CI, confidence interval; Ref., Reference.
p-value < 0.05 was considered statistically significant and indicated in bold.
** Reference (Ref) refers to the reference category that the other categorical variables are compared with in the multivariate logistic regression analysis.